Hancock Whitney Corp purchased a new stake in shares of Genpact Limited (NYSE:G - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 14,956 shares of the business services provider's stock, valued at approximately $642,000.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in Genpact by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 16,962,496 shares of the business services provider's stock worth $728,539,000 after buying an additional 61,376 shares during the period. Victory Capital Management Inc. raised its stake in Genpact by 18.1% in the 4th quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider's stock worth $423,205,000 after acquiring an additional 1,511,790 shares during the last quarter. Franklin Resources Inc. lifted its position in Genpact by 1.3% during the fourth quarter. Franklin Resources Inc. now owns 4,203,956 shares of the business services provider's stock valued at $180,560,000 after purchasing an additional 55,771 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of Genpact by 5.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,848,449 shares of the business services provider's stock worth $165,288,000 after purchasing an additional 208,759 shares during the period. Finally, Geode Capital Management LLC boosted its position in Genpact by 3.6% during the fourth quarter. Geode Capital Management LLC now owns 3,825,344 shares of the business services provider's stock worth $170,175,000 after purchasing an additional 133,938 shares in the last quarter. 96.03% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of brokerages have weighed in on G. Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and raised their price objective for the company from $44.00 to $55.00 in a report on Tuesday, January 21st. TD Cowen upgraded shares of Genpact from a "hold" rating to a "buy" rating and upped their price objective for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Mizuho raised their price objective on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Finally, Needham & Company LLC upped their target price on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Five equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, Genpact has an average rating of "Hold" and an average price target of $50.38.
Check Out Our Latest Report on Genpact
Insider Buying and Selling
In related news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the transaction, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at approximately $15,167,926.94. This trade represents a 4.20 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.80% of the stock is owned by company insiders.
Genpact Trading Up 1.0 %
NYSE G traded up $0.47 on Friday, hitting $49.71. 504,540 shares of the stock were exchanged, compared to its average volume of 1,329,100. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. Genpact Limited has a 52-week low of $30.38 and a 52-week high of $56.76. The company's 50-day moving average price is $49.40 and its two-hundred day moving average price is $46.60. The company has a market capitalization of $8.73 billion, a price-to-earnings ratio of 17.50, a P/E/G ratio of 1.84 and a beta of 1.06.
Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. Research analysts predict that Genpact Limited will post 3.21 EPS for the current year.
Genpact Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th were issued a $0.17 dividend. This is a positive change from Genpact's previous quarterly dividend of $0.15. The ex-dividend date of this dividend was Tuesday, March 11th. This represents a $0.68 annualized dividend and a dividend yield of 1.37%. Genpact's payout ratio is 23.94%.
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report